Export 12 results:
Author [ Title(Asc)] Type Year
Filters: Author is NEAD Study Group  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
K. J. Meador, Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., Loring, D. W., Mawer, G., Pennell, P. B., Smith, J. C., and Wolff, M. C., “In utero antiepileptic drug exposure: fetal death and malformations.”, Neurology, vol. 67, no. 3, pp. 407-12, 2006.
F
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.”, Brain, vol. 134, no. Pt 2, pp. 396-404, 2011.
K. Meador, Baker, G., Browning, N., Cohen, M., Clayton-Smith, J., Kalayjian, L., Kanner, A., Liporace, J., Pennell, P., Privitera, M., Loring, D., and Group, N. E. A. D. Study, “Foetal Antiepileptic Drug Exposure and Verbal Versus Non-Verbal Abilities at Three Years of Age”, Brain, vol. 134, pp. 396-404, 2011.
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.”, Lancet Neurol, vol. 12, no. 3, pp. 244-52, 2013.
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., Loring, D. W., and Group, N. E. A. D. Study, “Fetal Antiepileptic Drug Exposure and Cognitive Outcomes at Age 6 Years (NEAD Study): A Prospective Observational Study”, Lancet Neurol, vol. 12, pp. 244-252, 2013.
M. J. Cohen, Meador, K. J., Browning, N., May, R., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.”, Epilepsy Behav, vol. 29, no. 2, pp. 308-15, 2013.
E
K. J. Meador, Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.”, Neurology, vol. 78, no. 16, pp. 1207-14, 2012.
K. J. Meador, Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Effects of breastfeeding in children of women taking antiepileptic drugs.”, Neurology, vol. 75, no. 22, pp. 1954-60, 2010.
D
P. B. Pennell, Klein, A. M., Browning, N., Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Liporace, J. D., Privitera, M., Crawford, T., Loring, D. W., and Meador, K. J., “Differential effects of antiepileptic drugs on neonatal outcomes.”, Epilepsy Behav, vol. 24, no. 4, pp. 449-56, 2012.
, Baker, G. A., Clayton-Smith, J., Kalayjian, L. A., Liporace, J. D., Privitera, M., Crawford, T., Loring, D. W., Meador, K. J., and Group, N. E. A. D. Study, “Differential Effects of Antiepileptic Drugs on Neonatal Outcomes”, Epilepsy Behav, vol. 24, pp. 449-456, 2012.
C
K. J. Meador, Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., and Loring, D. W., “Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.”, N Engl J Med, vol. 360, no. 16, pp. 1597-605, 2009.
B
K. Meador, Baker, G., Browning, N., Clayton-Smith, J., Combs-Cantrell, D., Cohen, M., Kalayjian, L., Kanner, A., Liporace, J., Pennell, P., Privitera, M., Loring, D., and Group, N. E. A. D. Study, “Breastfeeding in Children of Women on Antiepileptic Drugs”, Neurology, vol. 75, pp. 1954-1960, 2010.